Oral fibrinogen-depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel-group and controlled clinical trial.
Chin Med J (Engl)
; 126(21): 4060-5, 2013 Nov.
Article
in En
| MEDLINE
| ID: mdl-24229674
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Endopeptidases
/
Fibrinogen
/
Stroke
Type of study:
Clinical_trials
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Chin Med J (Engl)
Year:
2013
Document type:
Article
Affiliation country: